Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Mar 20:3:107.
doi: 10.3389/fmicb.2012.00107. eCollection 2012.

Contribution of MS-Based Proteomics to the Understanding of Herpes Simplex Virus Type 1 Interaction with Host Cells

Affiliations

Contribution of MS-Based Proteomics to the Understanding of Herpes Simplex Virus Type 1 Interaction with Host Cells

Enrique Santamaría et al. Front Microbiol. .

Abstract

Like other DNA viruses, herpes simplex virus type 1 (HSV-1) replicates and proliferates in host cells continuously modulating the host molecular environment. Following a sophisticated temporal expression pattern, HSV-1 encodes at least 89 multifunctional proteins that interplay with and modify the host cell proteome. During the last decade, advances in mass spectrometry applications coupled to the development of proteomic separation methods have allowed to partially monitor the impact of HSV-1 infection in human cells. In this review, we discuss the current use of different proteome fractionation strategies to define HSV-1 targets in two major application areas: (i) viral-protein interactomics to decipher viral-protein interactions in host cells and (ii) differential quantitative proteomics to analyze the virally induced changes in the cellular proteome. Moreover, we will also discuss the potential application of high-throughput proteomic approaches to study global proteome dynamics and also post-translational modifications in HSV-1-infected cells that will greatly improve our molecular knowledge of HSV-1 infection.

Keywords: HSV-1; fractionation; labeling; mass spectrometry; proteomics.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Current and future applications of mass spectrometry to HSV-1 infection. Schematic representation of how proteomic technologies have been used to detect and identify HSV-1 targets in protein interactome experiments and also in differential quantitative protein expression studies. Gray boxes refer to alternative unexplored approaches that can be used to obtain more detailed information about the composition of HSV-1 particle (structural virology) and to analyze large-scale proteome perturbations and signaling pathways in host cells upon HSV-1 infection (Global and site specific quantitative glyco- and phosphoproteomics). IP, immunoprecipitation; LC–MS/MS, liquid chromatography coupled to tandem mass spectrometry; TAP, tandem affinity purification; Y2H, yeast two-hybrid system; MRM, multiple reaction monitoring; MS, mass spectrometry; 2-DE, two-dimensional electrophoresis; 2D-DIGE, two-dimensional fluorescence difference gel electrophoresis; TMT, Tandem mass tag isobaric labeling; SILAC, stable isotope labeling with amino acids in cell culture.

References

    1. Al-Dujaili L. J., Antrobus R., Grant K., Gangadharan B., Chittenden D., Everett R. D., Zitzmann N., Boutell C. (2009). Proteomic analysis of cells in the early stages of herpes simplex virus type-1 infection reveals widespread changes in the host cell proteome. Proteomics 9, 3913–392710.1002/pmic.200900207 - DOI - PubMed
    1. Argnani R., Marconi P., Volpi I., Bolanos E., Carro E., Ried C., Santamaria E., Pourchet A., Epstein A. L., Brocker T., Corrales F. J., Manservigi R., Goicoechea I., Foschini M., Hernandez-Alcoceba R. (2011). Characterization of herpes simplex virus 1 strains as platforms for the development of oncolytic viruses against liver cancer. Liver Int. 31, 1542–155310.1111/j.1478-3231.2011.02628.x - DOI - PubMed
    1. Bailer S. M., Haas J. (2009). Connecting viral with cellular interactomes. Curr. Opin. Microbiol. 12, 453–45910.1016/j.mib.2009.06.004 - DOI - PMC - PubMed
    1. Bernhard O. K., Diefenbach R. J., Cunningham A. L. (2005). New insights into viral structure and virus-cell interactions through proteomics. Expert Rev. Proteomics 2, 577–58810.1586/14789450.2.4.577 - DOI - PubMed
    1. Boersema P. J., Raijmakers R., Lemeer S., Mohammed S., Heck A. J. (2009). Multiplex peptide stable isotope dimethyl labeling for quantitative proteomics. Nat. Protoc. 4, 484–49410.1038/nprot.2009.21 - DOI - PubMed

LinkOut - more resources